Amoquin

Amoquin
Amoquin tablets are indicated for the treatment of P. falciparum malaria cases resistant to both chloroquine and sulphadoxine pyrimethamine combination
Product | Molecule |
---|---|
Amoquin Syrup |
Amodiaquine |
Amoquin Tablets |
Amodiaquine |
Molecule: Amodiaquine
Formulation: Amodiaquine 50mg/5ml, Syrup
Packaging Unit: 60ml Syrup
Dosage: Adults & children > 6 years : 10mg / kg of body weight in a single dose (i.e. 3 tablets)
Molecule: Amodiaquine
Formulation: Amodiaquine 200mg Tablets
Packaging Unit: 25 x 3 Tablets
Dosage: For the treatment of falciparum malaria and treatment of uncomplicated chloroquin resistances Vivax malaria : 10mg/Kg daily for 3 days
Indications
Treatment of malaria attacks. Individual prophylaxis
Pharmacological Class
Amino-4 quinoline derivative
Pharmacological Properties
Schizonticide
Mechanism Of Action
Schizonticide in the endo-erythrocyte phase. It has no action on the exo-erythrocyte forms that are fixed in the liver
Side Effects
Nausea, anorexia
Contraindications
Hypersensitivity to one of the components. History of liver and /or blood disorder at the time of the treatment.
Observations
It exerts action on a number of strains of plasmodium falciparum resistant to chloroquine. To be taken after meals
Recent Posts